ICU MED INC's ticker is ICUI and the CUSIP is 44930G107. A total of 293 filers reported holding ICU MED INC in Q4 2018. The put-call ratio across all filers is 0.45 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $4,962,564 | +19.6% | 41,790 | +8.1% | 0.00% | +33.3% |
Q1 2024 | $4,149,957 | +8.9% | 38,669 | +1.2% | 0.00% | 0.0% |
Q4 2023 | $3,809,569 | -16.2% | 38,195 | 0.0% | 0.00% | -25.0% |
Q3 2023 | $4,545,587 | -34.2% | 38,195 | -1.5% | 0.00% | -33.3% |
Q2 2023 | $6,911,634 | +11.1% | 38,788 | +2.8% | 0.01% | 0.0% |
Q1 2023 | $6,222,291 | -5.8% | 37,720 | -10.1% | 0.01% | 0.0% |
Q4 2022 | $6,604,554 | -8.7% | 41,939 | -12.7% | 0.01% | -14.3% |
Q3 2022 | $7,232,000 | +1.7% | 48,020 | +11.1% | 0.01% | 0.0% |
Q2 2022 | $7,108,000 | -28.9% | 43,237 | -3.7% | 0.01% | -12.5% |
Q1 2022 | $10,001,000 | -6.5% | 44,918 | -0.4% | 0.01% | +14.3% |
Q4 2021 | $10,700,000 | +1.9% | 45,085 | +0.2% | 0.01% | -12.5% |
Q3 2021 | $10,501,000 | +13.8% | 44,997 | +0.4% | 0.01% | +14.3% |
Q2 2021 | $9,228,000 | -7.0% | 44,838 | -7.1% | 0.01% | -12.5% |
Q1 2021 | $9,918,000 | -6.1% | 48,275 | -2.0% | 0.01% | 0.0% |
Q4 2020 | $10,564,000 | +40.7% | 49,252 | +19.9% | 0.01% | +14.3% |
Q3 2020 | $7,509,000 | +1.1% | 41,084 | +1.9% | 0.01% | 0.0% |
Q2 2020 | $7,428,000 | -8.3% | 40,299 | +0.4% | 0.01% | -30.0% |
Q1 2020 | $8,097,000 | +5.7% | 40,132 | -2.0% | 0.01% | +42.9% |
Q4 2019 | $7,659,000 | +23.3% | 40,932 | +5.2% | 0.01% | +16.7% |
Q3 2019 | $6,210,000 | +16.0% | 38,909 | +83.1% | 0.01% | 0.0% |
Q2 2019 | $5,354,000 | +1.1% | 21,253 | -3.9% | 0.01% | -14.3% |
Q1 2019 | $5,296,000 | -6.0% | 22,127 | -9.9% | 0.01% | -12.5% |
Q4 2018 | $5,637,000 | -15.6% | 24,548 | +3.9% | 0.01% | -11.1% |
Q3 2018 | $6,682,000 | -1.0% | 23,631 | +2.8% | 0.01% | 0.0% |
Q2 2018 | $6,750,000 | +1.1% | 22,988 | -13.1% | 0.01% | -10.0% |
Q1 2018 | $6,675,000 | +10.1% | 26,447 | -5.8% | 0.01% | +25.0% |
Q4 2017 | $6,065,000 | +15.2% | 28,079 | -0.9% | 0.01% | 0.0% |
Q3 2017 | $5,267,000 | +13.9% | 28,342 | +5.8% | 0.01% | +14.3% |
Q2 2017 | $4,623,000 | +22.1% | 26,800 | +8.1% | 0.01% | +16.7% |
Q1 2017 | $3,787,000 | -4.1% | 24,800 | -7.5% | 0.01% | -14.3% |
Q4 2016 | $3,949,000 | +14.5% | 26,800 | -1.8% | 0.01% | +16.7% |
Q3 2016 | $3,450,000 | +5.9% | 27,300 | -5.5% | 0.01% | +20.0% |
Q2 2016 | $3,259,000 | -4.0% | 28,900 | -11.3% | 0.01% | 0.0% |
Q1 2016 | $3,394,000 | -18.5% | 32,600 | -11.7% | 0.01% | -28.6% |
Q4 2015 | $4,162,000 | +3.0% | 36,900 | 0.0% | 0.01% | 0.0% |
Q3 2015 | $4,041,000 | +31.6% | 36,900 | +15.0% | 0.01% | +40.0% |
Q2 2015 | $3,071,000 | +22.8% | 32,100 | +11.8% | 0.01% | +66.7% |
Q1 2015 | $2,501,000 | 0.0% | 28,700 | 0.0% | 0.00% | 0.0% |
Q4 2014 | $2,501,000 | +4.9% | 28,700 | -22.7% | 0.00% | 0.0% |
Q3 2014 | $2,384,000 | +6.1% | 37,149 | +0.5% | 0.00% | 0.0% |
Q2 2014 | $2,247,000 | -15.5% | 36,949 | -17.1% | 0.00% | -25.0% |
Q1 2014 | $2,659,000 | -3.4% | 44,548 | +4.7% | 0.00% | 0.0% |
Q4 2013 | $2,754,000 | +41.0% | 42,558 | +48.0% | 0.00% | 0.0% |
Q3 2013 | $1,953,000 | +24.6% | 28,747 | +32.2% | 0.00% | +33.3% |
Q2 2013 | $1,567,000 | – | 21,747 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Sandhill Capital Partners LLC | 91,082 | $20,915,000 | 3.45% |
CROWN ADVISORS MANAGEMENT, INC. | 14,000 | $3,215,000 | 3.34% |
PURA VIDA INVESTMENTS, LLC | 65,119 | $14,953,000 | 2.98% |
Lyon Street Capital, LLC | 11,105 | $2,550,000 | 2.56% |
GW&K Investment Management, LLC | 412,350 | $94,688,000 | 1.87% |
Penn Capital Management Company, LLC | 51,722 | $14,451,000 | 1.43% |
Hotaling Investment Management, LLC | 6,351 | $1,458,000 | 1.19% |
PFM Health Sciences, LP | 175,758 | $40,359,000 | 1.07% |
DIXON HUBARD FEINOUR & BROWN INC/VA | 12,430 | $2,854,000 | 1.06% |
GAM Holding AG | 90,452 | $20,769,000 | 1.05% |